These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24097168)

  • 1. External defibrillation on an implantable defibrillator.
    Chiladakis J; Zagkli F; Alexopoulos D
    J Anesth; 2014 Apr; 28(2):312. PubMed ID: 24097168
    [No Abstract]   [Full Text] [Related]  

  • 2. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
    Della Bella P
    Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of incessant ventricular tachycardia in a 39-year-old woman with cardiomyopathy.
    Schuster MM
    Am J Crit Care; 1997 Nov; 6(6):467-71. PubMed ID: 9354226
    [No Abstract]   [Full Text] [Related]  

  • 4. When an AED meets an ICD... Automated external defibrillator. Implantable cardioverter defibrillator.
    Calle PA; Buylaert W
    Resuscitation; 1998 Sep; 38(3):177-83. PubMed ID: 9872639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical predictors of defibrillation energy requirements.
    Neuzner J; Bahawar H; Berkowitsch A; Michel U; Schlepper M; Pitschner HF
    Am J Cardiol; 1997 Jan; 79(2):205-6. PubMed ID: 9193027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy.
    Cawley PJ; Al-Khatib SM
    Am Heart J; 2004 May; 147(5):790-1. PubMed ID: 15131532
    [No Abstract]   [Full Text] [Related]  

  • 8. Irregular ventricular tachycardia underdetected by implantable cardioverter defibrillator device.
    Manolis AG; Kourouklis S; Chatzis D; Kouvelas K; Kyriakides Z
    Cardiol J; 2008; 15(3):281-3. PubMed ID: 18651422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmias in the intensive care patient.
    Trappe HJ; Brandts B; Weismueller P
    Curr Opin Crit Care; 2003 Oct; 9(5):345-55. PubMed ID: 14508146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden death].
    ACC/AHA/ESC
    Kardiologiia; 2011; 51(7):65-96. PubMed ID: 21878088
    [No Abstract]   [Full Text] [Related]  

  • 12. Ventricular Tachycardia Ablation in Patients With Implantable Cardioverter Defibrillators Should No Longer Be a Therapy of Last Resort.
    Kanagasundram AN; John RM; Stevenson WG
    Circulation; 2018 May; 137(18):1885-1887. PubMed ID: 29712693
    [No Abstract]   [Full Text] [Related]  

  • 13. Why the antiarrhythmics versus implantable defibrillator (AVID) trial sets the wrong precedent.
    Fogoros RN
    Am J Cardiol; 1997 Sep; 80(6):762-5. PubMed ID: 9315584
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of ventricular tachycardia.
    Luther V; Nijjer SS; Lefroy DC
    Br J Hosp Med (Lond); 2017 Jan; 78(1):C6-C9. PubMed ID: 28067552
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac manifestations in Emery-Dreifuss muscular dystrophy.
    Faiella W; Bessoudo R
    CMAJ; 2018 Dec; 190(48):E1414-E1417. PubMed ID: 30510046
    [No Abstract]   [Full Text] [Related]  

  • 16. Digitalis-related electric storm short after ICD implantation.
    Margos PN; Margos NP; Delakis IK; Kokotos GC; Filippou KS; Andrikopoulos GK; Stefanidis AS
    Hellenic J Cardiol; 2021; 62(6):480-484. PubMed ID: 33227450
    [No Abstract]   [Full Text] [Related]  

  • 17. Lidocaine-related increase in defibrillation threshold.
    Peters RW; Gilbert TB; Johns-Walton S; Gold MR
    Anesth Analg; 1997 Aug; 85(2):299-300. PubMed ID: 9249103
    [No Abstract]   [Full Text] [Related]  

  • 18. Interactions between drugs and devices: experimental and clinical studies.
    Manz M; Jung W; Lüderitz B
    Am Heart J; 1994 Apr; 127(4 Pt 2):978-84. PubMed ID: 8160602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant amiodarone and the implantable cardioverter-defibrillator: is there a place?
    McCollam PL; Nappi JM
    Ann Pharmacother; 1993 Jun; 27(6):736-41. PubMed ID: 8329797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
    Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
    N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.